Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Supreme Court to hear PIL seeking direction to govt for banning unregulated medical devices

      Supreme Court to hear PIL seeking direction to govt for banning unregulated medical devices

      Medical Dialogues Bureau16 Feb 2020 10:45 AM IST
      New Delhi: The Supreme Court will on February 14 hear the PIL (Public Interest Litigation) filed by a doctor, asking for directions to the Central...
      Complaints against Anti TB Dept, RITES India, Central Medical Service Society dismissed by CCI

      Complaints against Anti TB Dept, RITES India, Central Medical Service Society dismissed by CCI

      Medical Dialogues Bureau16 Feb 2020 10:30 AM IST
      The order came after it was alleged that the Central Medical Service Society and RITES India had published tenders for procurement of anti-TB and...
      Granules India gets tentative USFDA nod for generic version of Mucinex ER Tablets

      Granules India gets tentative USFDA nod for generic version of Mucinex ER Tablets

      Medical Dialogues Bureau15 Feb 2020 11:00 AM IST
      New Delhi: Drugmaker Granules India Limited recently announced that the company has received tentative approval from the US Food & Drug...
      Natco Pharma net profit slips 35pc to Rs 104 crore in Q3

      Natco Pharma net profit slips 35pc to Rs 104 crore in Q3

      Medical Dialogues Bureau15 Feb 2020 10:30 AM IST
      New Delhi: Drug firm Natco Pharma on Wednesday reported a 34.46 per cent drop in consolidated net profit to Rs 104.4 crore for the quarter ended...
      Merck introduces BrightLab, cloud-based instrument connectivity platform for research scientists

      Merck introduces BrightLab, cloud-based instrument connectivity platform for research scientists

      Medical Dialogues Bureau15 Feb 2020 10:15 AM IST
      Germany: Merck, a leading science and technology company, recently introduced its BrightLab cloud-based inventory management and instrument...
      Marksans Pharma Farmingdale facility gets Establishment Inspection Report from USFDA

      Marksans Pharma Farmingdale facility gets Establishment Inspection Report from USFDA

      Medical Dialogues Bureau14 Feb 2020 12:57 PM IST
      New Delhi: Drugmaker Marksans Pharma Ltd. recently announced that the company has received Establishment Inspection Report (EIR) from the US...
      Coronavirus: Gilead drug remdesivir raises hope for China trials

      Coronavirus: Gilead drug remdesivir raises hope for China trials

      Medical Dialogues Bureau14 Feb 2020 12:42 PM IST
      A state-run Chinese research institute applied last week fora patent to use Gilead's experimental drug- remdesivir against the new coronavirus.
      Bayer, Nuvisan ink pact to create new research unit in Berlin

      Bayer, Nuvisan ink pact to create new research unit in Berlin

      Medical Dialogues Bureau14 Feb 2020 10:30 AM IST
      The strategic partnership will lay the foundation for a brand-new research entity to be established by Nuvisan in Berlin. At the same time, it will...
      NIH-Funded Clinical Trial to test safety of dapivirine vaginal ring, PrEP in pregnant women

      NIH-Funded Clinical Trial to test safety of dapivirine vaginal ring, PrEP in pregnant women

      Medical Dialogues Bureau14 Feb 2020 10:00 AM IST
      The dapivirine vaginal ring slowly releases the anti-HIV drug dapivirine in the vagina and is replaced once a month. Two large, Phase 3 clinical...
      Philips announces DEFINE GPS global multicenter study to assess outcomes of PCI procedures guided by integrated iFR and interventional X-ray images

      Philips announces DEFINE GPS global multicenter study to assess outcomes of PCI procedures guided by integrated iFR and interventional X-ray images

      Medical Dialogues Bureau13 Feb 2020 1:44 PM IST
      Amsterdam: Royal Philips has announced a new randomized controlled trial to assess patient outcomes after receiving a percutaneous coronary...
      Lupin Pithampur unit gets 2 USFDA observations

      Lupin Pithampur unit gets 2 USFDA observations

      Medical Dialogues Bureau13 Feb 2020 12:52 PM IST
      The inspection of the company's Pithampur Unit-I facility by the United States Food and Drug Administration (USFDA) has been completed, Lupin said in...
      MEDICREA UNiD IB3D Patient-Matched interbody cages get USFDA clearance

      MEDICREA UNiD IB3D Patient-Matched interbody cages get USFDA clearance

      Medical Dialogues Bureau13 Feb 2020 10:00 AM IST
      New York: MEDICREA, pioneering the transformation of spinal surgery through artificial intelligence, predictive modeling and patient specific implants...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok